معرفی
Joel Collier is the Theodore Kennedy Professor of Biomedical Engineering and Associate Dean for Doctoral Education at Duke University's Pratt School of Engineering. He holds a PhD from Northwestern University (2003). His research focuses on designing biomaterials to control adaptive immune responses, particularly using self-assembling peptides, proteins, and bioconjugates to create nanofibers, gels, and particles for biomedical applications like treating infectious diseases, cancer, and chronic inflammation.
- Affiliations: Duke University, Pratt School of Engineering, Department of Biomedical Engineering
- Education: PhD in Biomedical Engineering, Northwestern University, 2003
His lab develops immunotherapies and vaccines, emphasizing mucosal delivery (sublingual, intranasal) and adjuvant-free systems. Recent work includes anti-inflammatory nanofiber therapies for conditions like inflammatory bowel disease and psoriasis. Key publications focus on peptide-based platforms for HIV, cancer, and UTI prevention.
Awards:
- Clemson Award for Basic Research (2024)
- Lois and John L. Imhoff Distinguished Teaching Award (2020)
- Fellow, AIMBE (2017)
Teaching spans graduate and undergraduate courses in biomedical engineering, including advanced topics and independent studies. His lab collaborates widely to translate biomaterials research into clinical applications, emphasizing global health relevance and scalability.
